Mycobacterium tuberculosis and Rifampin Resistance, United Kingdom

Mycobacterium tuberculosis and Rifampin Resistance, United Kingdom

The United Kingdom Health Protection Agency Mycobacterium Reference Unit offers a national "Fastrack" molecular service for detecting Mycobacterium tuberculosis complex (MTBC) and rifampin resistance by using the INNO-LiPA Rif.TB assay. We analyzed the service in a routine, nontrial contex...

Full description

Bibliographic Details
Main Authors:	I-Ching Sam, Francis Drobniewski, Philip More, Melanie Kemp, Timothy Brown
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2006-05-01
Series:	Emerging Infectious Diseases
Subjects:	Tuberculosis multidrug resistant rifampin DNA probes United Kingdom research
Online Access:	https://wwwnc.cdc.gov/eid/article/12/5/04-1339_article

Similar Items

Identification of Mycobacterium tuberculosis and Rifampin Resistance in Pulmonary and Extra-pulmonary Clinical Specimens Using the Gene Xpert MTB/RIF Assay
by: Fahimeh Azadi, et al.
Published: (2021-07-01)

Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
by: Ameeta S. Kalokhe, et al.
Published: (2012-03-01)

rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
by: Li M, et al.
Published: (2021-10-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Identifying Mycobacterium Tuberculosis Resistance to Rifampin by Multiplex Specific PCR Method
by: Masjedi M.R, et al.
Published: (2011-03-01)

Identifying Mycobacterium Tuberculosis Resistance to Rifampin by Multiplex Specific PCR Method
by: F Din Mohammadi, et al.
Published: (2011-04-01)

Rapid prediction of multi-drug resistance in clinical specimens of Mycobacterium tuberculosis.
by: Ndimande, Bongiwe Olga.
Published: (2012)

Multidrug-resistant Mycobacterium tuberculosis in HIV-Infected Persons, Peru
by: Pablo E. Campos, et al.
Published: (2003-12-01)

Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
by: Maya Habous, et al.
Published: (2019-01-01)

Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay
by: Raquel de A Maschmann, et al.
Published: (2011-03-01)

Etymologia: Rifampin
by: Ronnie Henry
Published: (2018-03-01)

Molecular Identification of Mycobacterium tuberculosis and Analysis of Its Resistance to Rifampin in Sputa From Tuberculosis Suspected Patients
by: M. Syaifudin
Published: (2010-08-01)

Sub-minimum inhibitory concentration of rifampin: a potential risk factor for resuscitation of Mycobacterium tuberculosis
by: Shahin Pourazar Dizaji, et al.
Published: (2017-11-01)

Comparison Of drrA And drrB Efflux Pump Genes Expression In Drug-Susceptible And -Resistant Mycobacterium tuberculosis Strains Isolated From Tuberculosis Patients In Iran
by: Khosravi AD, et al.
Published: (2019-11-01)

Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis
by: Diana B. Pedral-Sampaio, et al.

Rifampin resistance among individuals with extrapulmonary tuberculosis: 4 years of experience from a reference laboratory
by: S. Baghbanbashi, et al.
Published: (2021-03-01)

Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis
by: Valéria G. F. Pinheiro, et al.

Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
by: Huang YT, et al.
Published: (2018-08-01)

Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
by: Marian Loveday, et al.
Published: (2019-03-01)

Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, Iran
by: B. Motavaf, et al.
Published: (2021-05-01)

Prevalencia de la resistencia de Mycobacterium tuberculosis a quinolonas y fármacos inyectables en Colombia, 2012-2013
by: Claudia Llerena, et al.
Published: (2017-01-01)

The evaluation of the Xpert MTB/RIF in the diagnosis of mycobacterium tuberculosis complex and detection of rifampicin resistance in extrapulmonary (pleural and ascitic) fluid samples received for routine immunophenotypic analysis in a high-burden tuberculosis setting
by: Kilfoil, Kim Michelle
Published: (2016)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
by: Sirous M, et al.
Published: (2018-10-01)

Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients
by: Levin Thomas, et al.
Published: (2020-06-01)

Assessment of adherence to antituberculosis drug regimen among patients receiving isoniazid, rifampin and pyrazinamide: Kerman, Iran
by: Seyyed Mojtaba Sohrevardi, et al.
Published: (2019-07-01)

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis
by: Mônica C. Façanha, et al.

Evaluation of the frequency of resistance to 2 drugs (Isoniazid and Rifampin) by molecular investigation and it's risk factors in new cases of smear positive pulmonary tuberculosis in health centers under the cover of Jundishapur University of Medical Sciences in 2017
by: Shokrollah Salmanzadeh, et al.
Published: (2020-01-01)

Multidrug-resistant tuberculosis detection and characterization of mutations in mycobacterium tuberculosis by genotype MTBDRplus
by: Rajneesh Tripathi, et al.
Published: (2017-01-01)

Direct Detection of Rifampin-Resistant Mycobacterium tuberculosis in Respiratory Specimens Using Quantamatrix Multiplexed Assay Platform (QMAP) System: A Multicenter Study in Korea
by: Hye-young Wang, et al.
Published: (2018-08-01)

Evidenziazione molecolare di resistenza di Mycobacterium tuberculosis complex a rifampicina e isoniazide
by: Gian Lorenzo Molinari, et al.
Published: (2006-06-01)

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
by: Helen R. Stagg, et al.
Published: (2016-03-01)

Mycobacterium bovis Infection, United Kingdom
by: Robert M.M. Smith, et al.
Published: (2004-03-01)

Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico
by: R Zenteno-Cuevas, et al.
Published: (2009-05-01)

Detection of isoniazid and rifampin resistance of Mycobacterium tuberculosis by a multiplex allele-specific polymerase chain reaction (PCR) assay
by: Zeyneb Allegui, et al.
Published: (2012-01-01)

A Study on Diagnostic Evaluation of Two Different Rapid DNA Polymerase Chain Reaction Techniques Namely Gene Xpert Mycobacterium Tuberculosis/Rifampin (MTB/RIF) and Mycoreal Polymerase Chain Reaction in the Diagnosis of Endometrial Tuberculosis Considering Culture as Gold Standard
by: M Ashwini, et al.
Published: (2020-01-01)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
by: Kanchan Ajbani, et al.
Published: (2019-01-01)

Rifampin-Resistant Mycobacterium bovis BCG–Induced Disease in HIV-Infected Infant, Vietnam
by: Duc Nguyen Hong, et al.
Published: (2013-07-01)

Multiple rpoB Mutants of Mycobacterium tuberculosis and Second-order Selection
by: Igor Mokrousov
Published: (2004-07-01)

Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?
by: Nora Renz, et al.
Published: (2021-02-01)

Detección rápida de resistencia a drogas en Mycobacterium tuberculosis mediante PCR-SSCP y PCR- Heteroduplex
by: Róger Calderón E, et al.
Published: (2003-04-01)